EEF- Escola de Educação Física
URI Permanente desta comunidade
Navegar
Navegando EEF- Escola de Educação Física por Assunto "Aging"
Agora exibindo 1 - 2 de 2
Resultados por página
Opções de Ordenação
Item Effects of different strength training protocols on sarcopenia influencing parameters in older adults : a systematic review.(2022) Registre, Farah; Lopes, Lilian Maria Peixoto; Souza, Perciliany Martins de; Becker, Lenice Kappes; Borba, Diego de Alcantara; Ferreira Júnior, João Batista; Oliveira, Emerson Cruz de; Coelho, Daniel BarbosaIntroduction: Sarcopenia is characterized by the reduction of skeletal muscle mass and its functionality. Several of the parameters that influence sarcopenia are modified by strength training. Objective: To review the effects of different strength training protocols (frequency, duration, and intensity) on parameters that influence sarcopenia. Methods: This is a systematic review of original, quantitative, observational studies, published between 2010 in 2020, in English, Spanish and Portuguese, and indexed in the SciELO, PubMed, and CAPES databases. The terms used search were: “muscle strenght” (“força muscular”, “fuerza muscular”), “sarcopenia” (“sarcopenia”), “aging” (“envelhecimento”, “envejecimiento”), “olders” (“idosos”, “ancianos”), “strength training” (“treinamento de força/resistência”, “entrenamiento de fuerza”). 215 articles were retrieved and 11 met the inclusion criteria, being included in the review. Results: Among the 11 studies analyzed, it is observed that strength training applied in different protocols was efficient in improving parameters such as muscle mass and strength, body balance, and performance in diagnostic tests of sarcopenia. Conclusion: This review highlights the benefits of the practice of strength exercise in different protocols on parameters that influence the onset of sarcopenia in older adults. The exercise of strength is presented as an applicable, practical, and non-pharmacological means of preventing sarcopenia.Item Use of diuretics is associated with higher risk of sarcopenia in older adults with hypertension.(2022) Martins Junior, Francisco de Assis Dias; Mateo, Dahany Pamela Acta; Silva, Fábio Junior de Miranda; Moura, Samara Silva de; Oliveira, Emerson Cruz; Coelho, Daniel Barbosa; Bearzoti, Eduardo; Pinto, Kelerson Mauro de Castro; Oliveira, Lenice Kappes BeckerBackground: Sarcopenia is a disease that involves skeletal muscle mass loss and is highly prevalent in the older adult population. Moreover, the incidence of sarcopenia is increased in patients with hypertension. Objective: The study aimed to evaluate the association between the classes of the drugs used for arterial hypertension treatment and the presence or absence of sarcopenia. Methods: 129 older adults with hypertension were evaluated by the researchers who registered the participants medication for arterial hypertension treatment. Sarcopenia level was measured by anthropometric parameters, muscular strength, and functional capacity. The data were analyzed by one-way ANOVA followed by post-hoc test and Fisher’s exact test; statistical significance was set at 0.05. Results: Age was not different between women with different levels of sarcopenia, but significant differences were observed between men with absent sarcopenia (66.8±4.2 years) and men with probable sarcopenia (77.0±10.2 years). Individuals with absent sarcopenia showed higher handgrip strength (men: 33.8±7.4, women: 23.2±4.6 Kgf) in comparison with those with sarcopenia (men with probable sarcopenia: 9.5±3.3 Kgf, women with probable, confirmed, and severe sarcopenia: 11.7±2.5, 12.2±3.0, 11.8±1.8 Kgf, respectively). The analysis showed an association between the type of medication and degree of sarcopenia; diuretics were significantly associated with probable sarcopenia, and angiotensin II receptor blockers (alone or in combination with diuretics) was associated with absence of sarcopenia. Conclusions: In conclusion, handgrip strength was a good method to diagnose sarcopenia, and diuretics were associated with increased risk of sarcopenia in older adults with hypertension.